MétaCan
Menu
Back to cohort
Record W3023749488 · doi:10.1016/j.jalz.2007.04.155

P‐192: Tramiprosate decreases amyloid‐β induced ERK1/2 activity in primary rat neurons by a GABA‐independent pathway

2007· article· en· W3023749488 on OpenAlexaff
Barry Greenberg, Lara Fallon, Caroline Lagacé, Giovanna Sebastiani, Julie Paquette, Daniel Delorme

Bibliographic record

VenueAlzheimer s & Dementia · 2007
Typearticle
Languageen
FieldMedicine
TopicCholinesterase and Neurodegenerative Diseases
Canadian institutionsUniversité Laval
Fundersnot available
KeywordsNeuroprotectionMAPK/ERK pathwayPropidium iodidePhosphorylationMuscimolKinaseHippocampal formationProgrammed cell deathProtein kinase ACell biologyChemistryPharmacologyBiologyApoptosisAgonistEndocrinologyBiochemistryReceptor

Abstract

fetched live from OpenAlex

The mitogen-activated protein kinase (MAPK) family members, including extracellular signal regulated kinase (ERK1/2), are involved in neuronal cell death mediated by amyloid-β (Aβ). Aβ has been shown to induce activation of ERK1/2 in primary neurons (Rapoport. J Neurochem 2000, 74:125). Treatment of organotypic hippocampal cultures (OHC) with soluble oligomeric Aβ has been reported to result in ERK1/2 activation and contribute to cell death (Chong. J Biol Chem 2006:281). Tramiprosate (3-amino-1-propanesulfonic acid), presently in phase III trials for Alzheimer's disease, is neuroprotective against Aβ42-mediated toxicity in rat primary neurons and OHC. This study assessed the role of MAPK in this neuroprotective activity. Rat primary cortical/hippocampal neurons were treated with soluble Aβ42, and ERK1/2 phosphorylation and caspase 3/7 activity were assessed. OHC were treated with soluble Aβ42 ± U0126 (MEK1 inhibitor). Cellular mortality was assessed by propidium iodide uptake. Treatment of rat primary neurons with Aβ42 induced ERK1/2 phosphorylation, while coincubation with tramiprosate significantly reduced this effect. Tramiprosate preferentially inhibits ERK1/2 activation induced by an Aβ42 preparation that is predominantly in a β-sheet conformation rather than random coil. U0126 completely blocked Aβ42-induced ERK1/2 phosphorylation while muscimol, a potent GABAA receptor agonist, was inactive. Together these results demonstrate the GABAA-independent activity of tramiprosate on ERK1/2. Treatment of OHC with Aβ42 induced ERK1/2 phosphorylation in all hippocampal regions while U0126 was completely protective against Aβ42-induced cell death. The effect of tramiprosate on Aβ42-mediated ERK1/2 activation in OHC is under investigation. Tramiprosate is neuroprotective in rat primary neurons at least in part via inhibition of Aβ42-induced activation of ERK1/2 by a GABAA-independent mechanism. Interestingly, tramiprosate binds to the GABAA receptor with high affinity and inhibits Aβ42-induced caspase-3/7 activation in rat primary neurons through a GABAA-dependent mechanism (See Galarneau et al., poster presentation at this meeting). Because muscimol was inactive against Aβ42-induced ERK1/2 phosphorylation, and U0126 did not protect against Aβ42-induced caspase 3/7 activation, these results suggest that the neuroprotective activity of tramiprosate involves at least two potentially independent and complementary mechanisms, one GABAergic and the other non-GABAergic.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: Bench or experimental
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.014

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.032
GPT teacher head0.287
Teacher spread0.255 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2007
Admission routes1
Has abstractyes

Explore more

Same venueAlzheimer s & DementiaSame topicCholinesterase and Neurodegenerative DiseasesFrench-language works237,207